Scott Burrows
Directeur Financier/CFO chez SPYRE THERAPEUTICS, INC.
Fortune : 5 M $ au 30/04/2024
Postes actifs de Scott Burrows
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SPYRE THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/09/2023 | - |
| Directeur Financier/CFO | 01/09/2023 | - |
Historique de carrière de Scott Burrows
Anciens postes connus de Scott Burrows
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 01/04/2021 | 31/08/2023 |
| Directeur Financier/CFO | 01/04/2021 | 31/08/2023 | |
| Corporate Officer/Principal | 01/05/2019 | 01/04/2021 | |
Shire International GmbH (Switzerland)
 Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Investor Relations Contact | 01/03/2018 | 01/05/2019 |
Formation de Scott Burrows
| University of California, Los Angeles | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 4 |
| Suisse | 2 |
Opérationnelle
| Comptroller/Controller/Auditor | 2 |
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| SPYRE THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Shire International GmbH (Switzerland)
Shire International GmbH (Switzerland) Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire International GmbH is a pharmaceutical company based in Zug, Switzerland. The Swiss company develops, manufactures, and markets pharmaceuticals. | Health Technology |
- Bourse
- Insiders
- Scott Burrows
- Expérience